[ad_1]
Equity investors appear to have moved past the “growth scare” fears that helped to inspire the summertime bust-up that nearly landed the S&P 500 in correction territory earlier this month.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...